Tagamet®: A medicine that changed people’s lives
FDA approved Tagamet® — a widely prescribed treatment for ulcers and heartburn — bringing relief to millions.
1970s, transformed the lives of millions of people. Sold under the trademark Tagamet®, it was the first effective anti-ulcer drug and had a revolutionary impact on treatment. Tagamet® profoundly decreases acid secretion, thus promoting healing and avoiding the need for surgery.
The American Chemical Society and the Royal Society of Chemistry designated the discovery of histamine H2-receptor antagonists, which led to the development of Tagamet®, as an International Historic Chemical Landmark in ceremonies in Harlow, United Kingdom, on November 24, 1997, and in King of Prussia, Pennsylvania, on February 27, 1998.
Visit National Historic Chemical Landmarks to read more about Tagamet®.